FINWIRES · TerminalLIVE
FINWIRES

インド株式市場は木曜日、銀行株の売り浴びせと原油価格の急騰が重荷となり、下落幅を拡大した。

-- インドの主要株価指数は木曜日、銀行株の売りと原油価格の上昇に押され、大幅に下落した。 BSEセンセックス指数は852.49ポイント(1.1%)下落し、77,664.00で取引を終えた。NSEニフティ50指数は205.05ポイント(0.8%)下落し、24,173.05で引けた。 中東情勢の緊迫化と米イラン協議をめぐる不確実性を背景に、市場心理は依然として軟調だった。新たな海上事件の報道や次回の交渉の見通しが不透明なことから、停戦延長にもかかわらず投資家は慎重な姿勢を崩さなかった。 ユニオン・バンク・オブ・インディア(NSE:UNIONBANK、BOM:532477)は、第4四半期決算で前年同期の501億ルピーから550億ルピーに増益したと発表したが、株価は7%以上下落した。シプラ(NSE:CIPLA、BOM:500087)の株価は、子会社がアルブテロール硫酸塩吸入エアゾールについて米国FDAの承認を取得したことを受け、約6%上昇した。同製品は2027年度上半期に発売される予定だ。

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL